Last reviewed · How we verify
Hypertensives
At a glance
| Generic name | Hypertensives |
|---|---|
| Sponsor | University of Delaware |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Acute and Chronic Effects of Combined Training on BP in Hypertensives (NA)
- Focusing on the Menopausal Transition to Improve Mid-Life Women's Health (PHASE2, PHASE3)
- Arogya Sangama: 3 Way Partnership of People, Providers, and Panchayat for Health (NA)
- Treatment With Endovascular Intervention for STroke Patients With Existing Disability
- Hypertension Chronobiome
- Comparing Bisoprolol and Valsartan-Amlodipine for Hypertension (PHASE4)
- Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension (PHASE4)
- Comparison Between the Use of Phentolamine Versus Glyceryl Trinitrate for Their Effect on Renal Function in Pre-eclampsia Patients in ICU (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hypertensives CI brief — competitive landscape report
- Hypertensives updates RSS · CI watch RSS
- University of Delaware portfolio CI